FDA Warning Letter — Aspire Pharmaceuticals, Inc.
The FDA took a Warning Letter action against Aspire Pharmaceuticals, Inc. on November 22, 2022 (Somerset, NJ). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.
Action Details
- Facility
- Aspire Pharmaceuticals, Inc.
- Date
- November 22, 2022
- Fiscal Year
- 2023
- Product Type
- Drugs
- Center
- CDER
- Location
- Somerset, NJ (United States)